NorthWest Biotherapeutics Inc (NWBO)

[KRISGO]

• Kalinski technology clinical trial preparations advancing
An updated trial design and IND package for an initial clinical trial involving the Company’s licensed Kalinski technology were completed during the first quarter. The lead medical institution for the clinical trial has been determined, and the IND package has been submitted to the Institutional Review Board (IRB) at that institution. The Company anticipates submission to the FDA during the second quarter.